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Objectives: To develop predictive models to identify CHF and COPD patients at 
high risk of hospitalization within the next 6 months to be used for case manage-
ment outreach. DAtA sOurces: Data were extracted from several sources and 
included patient diagnoses, service utilization, lab data, and medication adherence 
from a large health insurance claims database, ZIP code level demographic data 
from the U.S. Census, patient level illness burden scores, medical episode group-
ers, Experian consumer and credit information, and call data between patients 
and customer service representatives. stuDy POPulAtiOn: All commercial and 
Medicare members who were identified with congestive heart failure (CHF) and 
chronic obstructive pulmonary disease (COPD) and who were continuously enrolled 
for at least 6 months during the model development period and 6 months during 
the predictive period were included. MethODs: Using three years of historical 
data from 2010 to 2012 and admissions between January and June 2013 as the target 
variable, the data were randomly split in half as training and validation data. The 
training data were used to build the predictive model. The validation data were used 
to evaluate model performance. Several algorithms were utilized to build predictive 
models: logistic regression, neural networks, and decision trees. The models were 
evaluated based on the lift chart and/or area under the ROC curve. The selected 
models were used to score data and predict future admissions. results: The key 
factors predicting admissions in the next 6 months included length of time identi-
fied with CHF and COPD, medication adherence, prior admissions, recent specialist 
visits, having had a customer call that mentioned ‘hospital bed/hospital stay’, and 
being on oxygen (for COPD). cOnclusiOns: Four models of predicting patients 
at highest risk of admission have been developed, which were used to generate a 
list of patients with high probability of admission for case management outreach.
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Objectives: To develop an analytical method which quantifies the reasonable 
limits for any incremental cost-effectiveness ratio (ICER) defined by the slope of a 
line connecting two points on the cost-benefit plane. MethODs: Assume that the 
ICER of a target technology vs. its comparator is defined with two points at each of 
which a pair of cost and benefit is given on the C(cost)-E(benefit) plane. In order to 
find a cost-benefit function connecting the two points, an analytical method was 
developed by means of curve-fitting technique with exponential and quadratic mod-
eling. The resultant cost-benefit function was further analytically expanded to the 
derivative, dC/dE, we call it “tangent limit”. Example calculations of the tangent lim-
its were conducted for each model. results: The analytical development resulted 
in the following equations of the cost-benefit function and the derivative for each 
modeling: C = Exp((E - p)/q) and dC/dE = (1/q) Exp((E - p)/q) for exponential model, 
whilst C = (1/q)E2 - p/q and dC/dE = 2E/q for quadratic model, where p and q are 
parameters determined by costs and benefits of the target technology and its com-
parator. Applying the equations for two hypothetical points, (7.6 QALY, US$100,000) 
and (8.6 QALY, US$150,000), we found that the ICER of 50 bounds with the lower and 
the upper limits, respectively, 40.6 and 60.8 US$(x1000)/QALY for exponential model, 
and as well, 46.9 and 53.1 for quadratic model. Those estimates were not so much 
different as the limits of 43.9 and 65.8 for the ICER of 54.1, obtained by the regression 
analysis presented in the ISPOR New Orleans 2013. cOnclusiOns: Our approach 
can offer a simple and science-based method to estimate boundaries for any ICER. 
It would be useful for negotiations and decisions in value-based pricing in which a 
range of ICER must be considered beyond a single threshold ratio.
PRM120
bIas when UsIng PRoPensIty scoRe Methods to adjUst foR covaRIates 
that aRe not confoUndeRs
Chia V.M., Page J.H.
Amgen, Inc, Thousand Oaks, CA, USA
Objectives: High-dimensional propensity score (PS) methods have been used in 
health care claims data to improve control of confounding by adjusting for a large 
number of covariates that may be proxies for unobserved factors. We have previ-
ously shown that PS models are biased for non-linear link functions when con-
founders were included. We conducted a simulation study to understand whether 
inclusion of covariates that are not confounders may also bias the association by 
estimating Monte Carlo mean bias, relative efficiency (RE) and coverage probability 
(CP) of log odds ratios when covariates only related to the exposure or only related 
to the outcome were included. MethODs: We conducted 1000 Monte Carlo simula-
tions, and estimated effect of exposure using logistic regression models. The propen-
sity score was included in the logistic model as a linear predictor or as a smoothed 
covariate using restricted cubic splines. Simulations were conducted for scenarios 
including 5, 15, and 25 covariates. results: Using the PS with 25 covariates related 
only to the binary exposure, Monte Carlo bias, standard error (SE), RE and CP were 
-0.002, 0.015, 1.34, and 0.94 when the PS was included as a smoothed covariate, and 
–0.002, 0.015, 1.31, and 0.94 when the PS was included as a linear covariate. The 
bias, SE, RE and CP for 25 covariates related to the binary outcome were 0.307, 0.096, 
21.6, and 0 when the PS was included as a linear covariate. Bias tended to increase 
with more covariates. cOnclusiOns: We observed minimal bias when using PS 
models where covariates were related only to the exposure, but substantial bias 
when the covariates were related to the outcome. PS models may not be appropriate 
for logistic models because these models do not adequately deal with errors in the 
outcome due to the covariate.
Objectives: Genetic programming is an Evolutionary Computing technique, 
inspired by biological evolution, capable of discovering complex non-linear pat-
terns in large datasets. Despite the potential advantages of genetic programming 
over standard statistical methods, its applications to survival analysis are at best 
rare, primarily because of the difficulty in handling censored data. The aim of this 
study was to demonstrate the utility of genetic programming for the automatic 
development of clinical prediction models using cardiovascular disease as a case 
study. MethODs: We compared genetic programming and the commonly used 
Cox regression technique in the development of a cardiovascular risk score using 
data from the SMART study, a prospective cohort study designed to identify predic-
tors of future cardiovascular events in patients with symptomatic cardiovascular 
disease. The primary outcome was any cardiovascular event, comprising cardiovas-
cular death and non-fatal stroke and myocardial infarction. The predictive ability 
of the model was assessed in terms of discrimination and calibration. results: 
3,873 patients were enrolled in the study 1996–2006, aged 19–82 years and with 
460 cardiovascular events. The discrimination of both models was comparable; the 
C-index of the genetic programming model being smaller (0.65; 95% CI: 0.63–0.66) 
but not significantly different from that of the Cox regression model (0.71; 0.67–0.75). 
The calibration of both models was also comparable, indicating similar disagree-
ment between observed and predicted risks. cOnclusiOns: Using empirical data, 
we demonstrated that a prediction model developed by the novel technique of 
genetic programming has a comparable predictive ability to that of Cox regression. 
The genetic programming model was more complicated but was developed in an 
automated fashion and did not require the expertise needed for survival analysis. 
Genetic programming seems a promising technique for the automated development 
of clinical prediction models for diagnostic and prognostic purposes.
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Objectives: To develop and test a novel approach to estimate the ICER via a new 
bootstrap approach based upon the sample coefficient of variance and optimized via 
computational intelligence. MethODs: A novel bootstrap ICER estimation approach 
was developed that incorporated the sample coefficient of variance to better capture 
information within cost-effectiveness data. In this derivation, an optimal design 
value parameter was also obtained via computational intelligence. Across illustra-
tive cost and outcome correlation structures and sample sizes, a simulation study 
of 1111 replications with 999 bootstrap resamples each was conducted utilizing 
MatLab R2012b. Comparative results of point estimates versus the existing bootstrap 
method were presented as relative efficiencies, with 95% confidence intervals (CI) 
presented as coverage probability, coverage error, length, left and right bias, and 
relative bias. results: The proposed ICER yielded less statistical estimation error 
than the typical bootstrap approach across all cases, with the relative efficiency of 
point estimates ranging from +106.03% to +113.35%. An equal or improved coverage 
error for the CI was also consistently achieved, deviating from the population value 
by zero (i.e., perfect coverage) to 0.0200 versus from 0.0060 to 0.0210. Subsequently, 
an improved shortening of the CI length was noted. The relative bias suggested 
slightly more left bias and less right bias across both positive and negative cost and 
outcome correlation structures, reaching a maximum of 0.5238 for the proposed 
ICER versus 0.2222 for the usual bootstrap. cOnclusiOns: This novel method to 
estimate the ICER via the sample coefficient of variation found improvements in 
the relative efficiency of point estimators and in the coverage error and length of 
the 95% CI across all simulated cases. Irrespective of cost and outcome correlation 
structure, the relative bias of this ICER suggested a slight increase in potential left-
sided bias and decrease in right-sided bias versus the usual bootstrap.
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Objectives: Health care researchers often encounter missing values in many data-
sets. Ultimately, a patient record with missing fields can still carry valuable infor-
mation. This extra information becomes more important to keep in oncology and 
other rare disease studies where sample size is typically limited. The purpose of this 
study is to demonstrate that researchers can benefit from using Multiple Imputation 
(MI) approach to tackle missing value problems. MethODs: The model data from 
IMS claims (Dx) and retail prescription (Rx) contained year 2011 patient level CKD 
stage indications, longitudinal drug therapies, days of supplies, titration rates, 
Demographic characteristics, payment type, and physician specialties, etc. We built 
multivariate logistic models to identify Chronic Kidney Disease (CDK) patient stages 
using prescription data in order to further evaluate the prevalence, economic burden 
and market opportunities. Under the general assumption of missing at random 
(MAR), we used MI with regression method to impute the missing monotone and 
categorical values before the modeling process. results: The pooled results from 
5 MI imputed datasets were reported. Compared with the results from deterministic 
missing imputation approach, the MI showed larger standard error and wider 95% 
confidence interval. The wider CI reflected the additional data uncertainty from the 
missing values. CDK stage 4 (11.2%) had smallest proportion and it had lowest hit 
rate in the prediction model. MI approach showed more CDK stage 4 identifications 
than those from deterministic complete case analysis. cOnclusiOns: This study 
demonstrated that MI is capable of reflecting the underline uncertainty associated 
with the data by introducing random errors into the imputation process. MI can 
generate unbiased results and good standard error estimation when using appro-
priately. On the other hand, with the advent of modern computational technology, 
the MI becomes computationally simple and easy to use.
